Optovite B12 (Cyanocobalamin)

Cyanocobalamin serves as a cofactor for methionine synthase and methylmalonyl‑CoA mutase, enzymes essential for DNA synthesis, myelin formation, and conversion of homocysteine to methionine. By participating in these pathways, it enables proper red blood cell production and nerve health, correcting metabolic disturbances caused by cobalamin deficiency.

The dosage and frequency of Optovite B12 are determined by the prescribing clinician based on the patient’s clinical condition, laboratory values, and route of administration. Healthcare professionals tailor the regimen to achieve optimal correction of the deficiency while monitoring response and safety.

Cyanocobalamin is generally considered safe when used as directed, but its use during pregnancy or lactation should be based on a risk‑benefit assessment by the treating physician. If a deficiency is present, supplementation may be recommended to protect maternal and fetal health.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and necessary import documentation.

Optovite B12 provides cyanocobalamin in a sterile injectable form, which is suitable for rapid correction of deficiency via intramuscular, intravenous, or subcutaneous routes. Compared with oral cyanocobalamin, the injectable route bypasses gastrointestinal absorption barriers, offering reliable bioavailability for patients with malabsorption or severe deficiency.

Optovite B12 should be stored at ambient temperature, below 25 °C, in its original container. Protect the product from moisture, direct sunlight, and extreme temperature fluctuations to maintain potency and sterility.

The product is administered by a qualified healthcare professional via intramuscular, intravenous, or subcutaneous injection, depending on the clinical indication and patient needs. The injection site and technique follow standard aseptic practices.

Serious risks include anaphylactic or severe hypersensitivity reactions, which may present as rash, swelling, respiratory distress, or cardiovascular collapse. Immediate medical intervention is required if such symptoms occur after administration.

Patients with a known hypersensitivity to cyanocobalamin or any excipients in the formulation should avoid using Optovite B12. Additionally, individuals with a history of severe allergic reactions to injectable vitamins should be evaluated carefully before treatment.